Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.6K
Overview
85.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.7K
T Cell Types and Functions01:24

T Cell Types and Functions

3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depletion-Resistant CD4 T Cells Enhance Thymopoiesis During Lymphopenia.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Related Experiment Video

Updated: Mar 11, 2026

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.7K

Total Recall: Can We Reshape T Cell Memory by Lymphoablation?

M Nicosia1, A Valujskikh1

  • 1Glickman Urological Institute and Department of Immunology, Cleveland Clinic, Cleveland, OH.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|November 27, 2016
PubMed
Summary

Donor-reactive memory T cells threaten organ transplant success. Current lymphoablative therapies struggle against these resilient cells, necessitating new strategies for improved long-term allograft outcomes in sensitized patients.

Keywords:
T cell biologybasic (laboratory) research/sciencecellular biologyfusion proteins and monoclonal antibodiesimmunobiologyimmunosuppressantimmunosuppression/immune modulationlymphocyte biologytranslational research/science

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Murine Superficial Lymph Node Surgery
04:36

Murine Superficial Lymph Node Surgery

Published on: May 21, 2012

43.9K

Related Experiment Videos

Last Updated: Mar 11, 2026

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.7K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Murine Superficial Lymph Node Surgery
04:36

Murine Superficial Lymph Node Surgery

Published on: May 21, 2012

43.9K

Area of Science:

  • Transplantation immunology
  • Immunosuppression strategies
  • T cell biology

Background:

  • Donor-reactive memory T cells pose a significant challenge to successful organ transplantation.
  • Preexisting immunologic memory necessitates lymphoablative induction therapies for sensitized recipients.
  • Existing therapies aim to mitigate the impact of memory T cells but face limitations.

Purpose of the Study:

  • To review the effects of current lymphoablative strategies on memory T cells in transplantation.
  • To discuss the advantages of memory T cells in surviving depletion and expanding under lymphopenic conditions.
  • To explore novel research developments for enhancing lymphoablation efficacy and safety.

Main Methods:

  • Review of experimental and clinical transplantation studies.
  • Analysis of existing lymphoablative induction therapies.
  • Synthesis of current research on memory T cell behavior post-depletion.

Main Results:

  • Memory T cells exhibit enhanced survival and expansion capabilities compared to naive T cells under lymphopenic conditions.
  • Current lymphoablative strategies may not effectively eliminate donor-reactive memory T cells, limiting long-term allograft success.
  • Despite reducing early acute rejection, existing therapies fail to consistently improve long-term outcomes in sensitized recipients.

Conclusions:

  • The resilience of memory T cells to lymphoablation is a key factor in suboptimal long-term allograft outcomes.
  • Further research is needed to develop improved lymphoablative strategies that specifically target or overcome memory T cell persistence.
  • Optimizing lymphoablation is crucial for enhancing the efficacy and safety of organ transplantation in sensitized individuals.